Bioclinical features obtained in the different groups of patients
. | Controls N = 63 . | GH, overloaded N = 23 . | P* . | GH, depleted N = 14 . | P* . | DYSH N = 26 . | P* . | Cirrhosis N = 33 . | P* . |
---|---|---|---|---|---|---|---|---|---|
Age, y | 51 ± 12 | 44 ± 10 | NS | 56 ± 11 | NS | 55 ± 11 | NS | 52 ± 10 | NS |
BMI, kg/m2 | 24.2 ± 2.3 | 25.4 ± 3.9 | NS | 25.9 ± 2.3 | NS | 29.3 ± 4.4 | < .001 | 25.3 ± 5 | NS |
Albumin, g/L N: 35-50 | 42 ± 4 | 41.5 ± 4 | NS | 41 ± 3 | NS | 40 ± 4 | NS | 29 ± 6 | < .001 |
AST, IU/L N: 0-50 | 20 ± 5 | 30 ± 15 | < .05 | 22 ± 9 | NS | 27 ± 18 | NS | 60 ± 29 | < .001 |
ALT, IU/L N: 0-60 | 24 ± 9 | 51 ± 27 | < .01 | 29 ± 13 | NS | 44 ± 25 | < .05 | 38 ± 21 | < .05 |
Serum iron, μM N: 12.5-25 | 18.7 ± 5.7 | 33.9 ± 6 | < .0001 | 21 ± 5.8 | NS | 23.4 ± 5.7 | .01 | 19.7 ± 10.5 | NS |
Transferrin, g/L N: 1.7-3.5 | 2.14 ± 0.3 | 1.57 ± 0.3 | < .0001 | 2.1 ± 0.4 | NS | 2.05 ± 0.4 | NS | 1.75 ± 0.8 | .05 |
Transferrin saturation, % N: 23-45 | 35 ± 11 | 87 ± 16 | < .0001 | 40 ± 14 | NS | 47 ± 14 | < .01 | 56 ± 34 | < .05 |
Ferritin, μg/L N: 55-345 | 192 ± 104 | 1362 ± 1145 | < .001 | 48 ± 36 | < .001 | 767 ± 494 | < .001 | 651 ± 812 | < .05 |
NTBI, μM | 0.154 ± 0.328 | 0.761 ± 0.504 | < .001 | 0.221 ± 0.559 | NS | 0.381 ± 0.381 | NS | 0.385 ± 0.560 | NS |
LPI, μM | 0.038 ± 0.07 | 0.250 ± 0.289 | < .01 | 0.019 ± 0.127 | NS | 0.018 ± 0.03 | NS | 0.095 ± 0.4 | NS |
. | Controls N = 63 . | GH, overloaded N = 23 . | P* . | GH, depleted N = 14 . | P* . | DYSH N = 26 . | P* . | Cirrhosis N = 33 . | P* . |
---|---|---|---|---|---|---|---|---|---|
Age, y | 51 ± 12 | 44 ± 10 | NS | 56 ± 11 | NS | 55 ± 11 | NS | 52 ± 10 | NS |
BMI, kg/m2 | 24.2 ± 2.3 | 25.4 ± 3.9 | NS | 25.9 ± 2.3 | NS | 29.3 ± 4.4 | < .001 | 25.3 ± 5 | NS |
Albumin, g/L N: 35-50 | 42 ± 4 | 41.5 ± 4 | NS | 41 ± 3 | NS | 40 ± 4 | NS | 29 ± 6 | < .001 |
AST, IU/L N: 0-50 | 20 ± 5 | 30 ± 15 | < .05 | 22 ± 9 | NS | 27 ± 18 | NS | 60 ± 29 | < .001 |
ALT, IU/L N: 0-60 | 24 ± 9 | 51 ± 27 | < .01 | 29 ± 13 | NS | 44 ± 25 | < .05 | 38 ± 21 | < .05 |
Serum iron, μM N: 12.5-25 | 18.7 ± 5.7 | 33.9 ± 6 | < .0001 | 21 ± 5.8 | NS | 23.4 ± 5.7 | .01 | 19.7 ± 10.5 | NS |
Transferrin, g/L N: 1.7-3.5 | 2.14 ± 0.3 | 1.57 ± 0.3 | < .0001 | 2.1 ± 0.4 | NS | 2.05 ± 0.4 | NS | 1.75 ± 0.8 | .05 |
Transferrin saturation, % N: 23-45 | 35 ± 11 | 87 ± 16 | < .0001 | 40 ± 14 | NS | 47 ± 14 | < .01 | 56 ± 34 | < .05 |
Ferritin, μg/L N: 55-345 | 192 ± 104 | 1362 ± 1145 | < .001 | 48 ± 36 | < .001 | 767 ± 494 | < .001 | 651 ± 812 | < .05 |
NTBI, μM | 0.154 ± 0.328 | 0.761 ± 0.504 | < .001 | 0.221 ± 0.559 | NS | 0.381 ± 0.381 | NS | 0.385 ± 0.560 | NS |
LPI, μM | 0.038 ± 0.07 | 0.250 ± 0.289 | < .01 | 0.019 ± 0.127 | NS | 0.018 ± 0.03 | NS | 0.095 ± 0.4 | NS |
Results are expressed as the mean plus or minus SD. N indicates normal values; GH, genetic hemochromatosis; DYSH, dysmetabolic hepatosiderosis; NS, nonsignificant.
Comparison between groups and controls with Dunnett test